ResMed Inc - Asset Resilience Ratio
ResMed Inc (RMD) has an Asset Resilience Ratio of 0.06% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is ResMed Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how ResMed Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ResMed Inc total assets.
Liquid Assets Composition Over Time
This chart breaks down ResMed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ResMed Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.47 Million | 0.06% |
| Total Liquid Assets | $5.47 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: ResMed Inc maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ResMed Inc Industry Peers by Asset Resilience Ratio
Compare ResMed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026 |
Medical Instruments & Supplies | 8.17% |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987 |
Medical Instruments & Supplies | 0.01% |
|
Spineway
PA:ALSPW |
Medical Instruments & Supplies | -0.24% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for ResMed Inc (1999–2025)
The table below shows the annual Asset Resilience Ratio data for ResMed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 14.96% | $1.22 Billion | $8.17 Billion | +11.31pp |
| 2024-06-30 | 3.64% | $250.39 Million | $6.87 Billion | +0.08pp |
| 2023-06-30 | 3.56% | $240.31 Million | $6.75 Billion | -1.99pp |
| 2022-06-30 | 5.55% | $282.88 Million | $5.10 Billion | -0.69pp |
| 2021-06-30 | 6.25% | $295.28 Million | $4.73 Billion | -3.85pp |
| 2020-06-30 | 10.10% | $463.16 Million | $4.59 Billion | +6.51pp |
| 2019-06-30 | 3.58% | $147.13 Million | $4.11 Billion | -2.50pp |
| 2018-06-30 | 6.08% | $186.20 Million | $3.06 Billion | -9.65pp |
| 2017-06-30 | 15.73% | $545.43 Million | $3.47 Billion | -- |
| 2016-06-30 | 0.00% | $0.00 | $3.26 Billion | -- |
| 2015-06-30 | 0.00% | $0.00 | $2.18 Billion | -- |
| 2014-06-30 | 0.00% | $0.00 | $2.36 Billion | -- |
| 2013-06-30 | 0.00% | $0.00 | $2.21 Billion | -- |
| 2012-06-30 | 0.00% | $0.00 | $2.14 Billion | -- |
| 2011-06-30 | 0.00% | $0.00 | $2.07 Billion | -- |
| 2007-06-30 | 1.59% | $19.95 Million | $1.25 Billion | -0.60pp |
| 2004-06-30 | 2.19% | $12.02 Million | $549.15 Million | +0.77pp |
| 2003-06-30 | 1.42% | $6.53 Million | $459.60 Million | -3.89pp |
| 2002-06-30 | 5.31% | $19.98 Million | $376.19 Million | -16.42pp |
| 2001-06-30 | 21.73% | $62.62 Million | $288.09 Million | +18.52pp |
| 2000-06-30 | 3.21% | $3.71 Million | $115.59 Million | -3.02pp |
| 1999-06-30 | 6.23% | $5.60 Million | $89.90 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more